NANOVIRICIDES, INC. Increase (Decrease) in Other Operating Assets
NANOVIRICIDES, INC. (NNVC) reported Increase (Decrease) in Other Operating Assets of -$37.75 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2017-05-15
- NANOVIRICIDES, INC. increase (decrease) in other operating assets for the quarter ending 2017-03-31 was -$14.38K, a 337.75% decline year-over-year.
- NANOVIRICIDES, INC. increase (decrease) in other operating assets for the quarter ending 2016-12-31 was -$14.70K.
- NANOVIRICIDES, INC. increase (decrease) in other operating assets for the quarter ending 2016-09-30 was -$8.68K.
- NANOVIRICIDES, INC. increase (decrease) in other operating assets for the quarter ending 2016-03-31 was $6.05K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2017-03-31 | -$14.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$29.07K derived: sum of 2 quarters · filed 2017-05-15 | -$37.75K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$14.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$23.38K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$8.68K 10-Q · filed 2016-11-14 | ||
| 2016-03-31 | $6.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$7.89K derived: sum of 2 quarters · filed 2017-05-15 | -$27.34K 10-Q · filed 2017-05-15 |
| 2015-12-31 | -$13.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$33.39K 10-Q · filed 2017-02-14 | |
| 2015-09-30 | -$19.45K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |